News

4th Munich Biomarker Conference

The interdisciplinary programme of the European Networking Event for Personalized Medicine on November 25th-26th, 2014 is now nearly complete. More and more participants now also register to the partnering and submit their profiles.

The congress with exhibition and partnering connects researchers and physicians with the biotech and pharma industry. The presentations by international experts cover the following subjects.

Sessions:

  • Systems Approaches
  • Biomarker Discovery
  • Technology Highlights
  • Development Strategies
  • Big Data for Precision Medicine
  • Biomarkers for Early Detection and Prevention
  • Biomarkers for Disease Management

Confirmed Speakers are:

  • Rudi Balling, Director of the Luxembourg Centre for Systems Biomedicine
  • Erwin Böttinger, Director, The Charles Bronfman Institute for Personalized Medicine
  • Chris Chamberlain, UCB
  • Jens Dhein, Scientific Director, Abbott GmbH & Co. KG
  • John Field, Chair of Molecular Oncology, University of Liverpool
  • Hannes Hahne, Technische Universität München
  • Henry Hepburne-Scott, Serametrix
  • Bodo Lange, CEO, Alacris Theranostics GmbH
  • Sabine Lohmann, Roche Diagnostics GmbH
  • Adelbert Roscher, Biocrates AG and Ludwig-Maximilians-Universität München

In addition, an exhibition area presents latest technologies for biomarker research. The one-2-one Partnering System assists the participants in finding the most interesting dialogue partners and to agree on confidental meetings.

A limited number of exhibition booths and further sponsoring options are available.
CME points are applied for.

Venue and Time
Hilton Munich Park Hotel
November 25th-26th, 2014

Programme and Registration
www.m4.de/mbc


Newsletter

Subscribe

Archive